Ignite Creation Date:
2024-05-06 @ 8:12 PM
Last Modification Date:
2024-10-26 @ 3:22 PM
Study NCT ID:
NCT06283251
Status:
RECRUITING
Last Update Posted:
2024-02-28
First Post:
2024-02-22
Brief Title:
PediRISE Feasibility
Sponsor:
Dana-Farber Cancer Institute
Organization:
Dana-Farber Cancer Institute
Study Overview
Official Title:
Pilot Randomized Pediatric RISE Resource Intervention to Support Equity Feasibility Study
Status:
RECRUITING
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The goal of this research study is to learn whether investigators can successfully give the PediRISE program to families-in other words whether most families are interested in participating in a study about the PediRISE program including a 50-50 chance of receiving standard usual care and a 50-50 chance of receiving the PediRISE support program
The names of the study groups in this research study are
PediRISE Program Group
Usual Care Group
The names of the study groups in this research study are
PediRISE Program Group
Usual Care Group
Detailed Description:
This is a pilot multi-center randomized research study for the feasibility of the administration of the PediRISE program among 40 poverty exposed children with newly diagnosed cancer Randomization means there is an equal chance of being assigned to the PediRISE Program Group or the Usual Care Group
Study procedures include screening for eligibility study visits and completion of surveys and questionnaires
Participation in this study will last for about 6-months
It is expected that about 40 pediatric participants with parentsguardians will take part in this research study
This study is being supported by grants from the American Cancer Society and the Childrens Cancer Research Fund
Study procedures include screening for eligibility study visits and completion of surveys and questionnaires
Participation in this study will last for about 6-months
It is expected that about 40 pediatric participants with parentsguardians will take part in this research study
This study is being supported by grants from the American Cancer Society and the Childrens Cancer Research Fund
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None